| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |